Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar and Chemoradiotherapy in Locally Advanced Cervical Cancer
NCT04121975Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Aug 2019
- Primary completion
- Aug 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of endostar in Cervical Cancer (CC), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Progression-Free Survival rate at 1 year. Status: unknown.
02
Drugs
endostar
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04121975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04121975.